Search results for "LETTER TO THE EDITOR."

showing 10 items of 127 documents

Quantitative assessment is essential for interpreting lymphoscintigraphy: Response to Ramin Sadeghi's letter to the editor

2019

medicine.medical_specialtyLetter to the editorbusiness.industryGeneral EngineeringQuantitative assessmentGeneral Earth and Planetary SciencesMedicineMedical physicsbusinessGeneral Environmental ScienceRevista Española de Medicina Nuclear e Imagen Molecular (English Edition)
researchProduct

Letter to the Editor Regarding "Comparison of Different Hybrid Techniques for the Treatment of Multilevel Cervical Degenerative Disc Disease-Analysis…

2020

medicine.medical_specialtyLetter to the editorbusiness.industryMEDLINEIntervertebral Disc Degenerationmedicine.diseaseDegenerative disc diseaseInternal medicinemedicineCervical VertebraeHumansSurgeryNeurology (clinical)businessCervical Vertebrae Intervertebral Disc Degeneration Intervertebral Disc HumansIntervertebral DiscWorld neurosurgery
researchProduct

Response to Letter to the Editor: Outcome of Bleb Revision With Autologous Conjunctival Graft Alone or Combined With Donor Scleral Graft for Late-ons…

2021

medicine.medical_specialtyLetter to the editorbusiness.industrymedicine.medical_treatmentMitomycinScleral graftMitomycin CGlaucomaLate onsetTrabeculectomymedicine.diseaseOphthalmologyBlisterOphthalmologyMedicineTrabeculectomyHumansBleb (medicine)businessConjunctivaIntraocular PressureScleraJournal of glaucomaREFERENCE
researchProduct

Metabolomics of chronic obstructive pulmonary disease and obstructive sleep apnea syndrome : response to Maniscalco and Motta

2016

We appreciate Maniscalco and Motta’s comments on our recently published article “Fusion of the 1H NMR data of serum, urine and exhaled breath condensate in order to discriminate chronic obstructive pulmonary disease and obstructive sleep apnea syndrome” (Zabek et al. 2015) and we are grateful for the opportunity to clarify a number of points from our work. We are glad that the authors appreciated our data analysis and interpretation. Fusion of metabolomic data is an outstanding tool for a comprehensive description of patient’s phenotype that combines metabolic profiles acquired in different domains. Such an integrative approach is highly valued in the so-called ‘breathomics’ (Smolinska et a…

medicine.medical_specialtyPathologyEndocrinology Diabetes and MetabolismClinical BiochemistryDisease01 natural sciencesBiochemistry03 medical and health sciences0302 clinical medicineblood analysismedicineExhaled breath condensatebreath analysisIntensive care medicineLetter to the EditorPathologicalCOPDbusiness.industry010401 analytical chemistryOverlap syndromemedicine.diseaseObesity0104 chemical sciencesClinical trialObstructive sleep apnea030228 respiratory systembusiness
researchProduct

Endovascular management of a giant symptomatic gluteal artery aneurysm with selective arterial embolization

2017

A 78-year-old female presented to our department with pain and swelling in the left gluteal region. Physical examination revealed a large tender swelling in the left gluteal area simulating an abscess. However, pulsation was observed over the swelling that raised the suspicion of a vascular lesion. Therefore, contrast-enhanced computed tomography (CT) was done before trying any intervention. The scan demonstrated a large aneurysm originating from the left superior gluteal artery measuring 65 mm × 38 mm with a small intra-pelvic component and large extra-pelvic component in the gluteal area ( Figure 1 ).

medicine.medical_specialtyPhysical examination[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicine030204 cardiovascular system & hematology[ SDV.IB.MN ] Life Sciences [q-bio]/Bioengineering/Nuclear medicine03 medical and health sciences0302 clinical medicineAneurysmmedicine[INFO.INFO-IM]Computer Science [cs]/Medical ImagingRadiology Nuclear Medicine and imaging030212 general & internal medicineLeft gluteal regionGluteal ArteryAbscessLetter to the EditorComputingMilieux_MISCELLANEOUSmedicine.diagnostic_test[ INFO.INFO-IM ] Computer Science [cs]/Medical Imagingbusiness.industryArterial Embolizationmedicine.diseaseLeft superior gluteal arterySurgerybody regionsRadiologybusinessGluteal area
researchProduct

Reply to Athanassios Kyrgidis, Zisis Teleioudis and Konstantinos Vahtsevanos’ Letter to the Editor re: Christian Walter, Bilal Al-Nawas, Knut A. Gröt…

2009

medicine.medical_specialtyProstate cancerBisphosphonate-associated osteonecrosis of the jawLetter to the editorbusiness.industryUrologyGeneral surgerymedicineAdvanced diseasebusinessmedicine.diseaseSurgeryEuropean Urology
researchProduct

Procalcitonin for the diagnosis of invasive candidiasis: what is the evidence?

2017

Abstracts Procalcitonin is a widely used marker for the evaluation of infection and sepsis and to guide antibiotic therapy. During the last decade, several studies evaluated its role and diagnostic performance as a surrogate marker for the identification of Candida spp. in suspected invasive candidiasis. A low serum level and a favorable negative predictive value are the main findings for procalcitonin in this setting. The aim of this report is to provide an updated brief summary of the evidence supporting the use of PCT for the management of invasive candidiasis.

medicine.medical_specialtySepsiInvasive candidiasiCritical Care and Intensive Care MedicineProcalcitoninSepsis03 medical and health sciences0302 clinical medicineAntibiotic therapySepsismedicine030212 general & internal medicineIntensive care medicineLetter to the EditorCandida spp.Surrogate endpointbusiness.industrylcsh:Medical emergencies. Critical care. Intensive care. First aid030208 emergency & critical care medicineInvasive candidiasislcsh:RC86-88.9medicine.diseasebacterial infections and mycosesCandida spp.; Invasive candidiasis; Procalcitonin; Sepsis; Critical Care and Intensive Care MedicinePredictive valueInvasive candidiasisCandida sppbusinessProcalcitoninhormones hormone substitutes and hormone antagonistsJournal of Intensive Care
researchProduct

Natura abhorret a vacuo. Future perspectives of autologous fibrin glue. Is it time for reappraisal?

2017

medicine.medical_specialtySettore MED/27 - Neurochirurgiabusiness.industrySurgery03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisAutologous fibrin glueMedicineSurgeryNeurology (clinical)Fibrin gluebusinessLetter to the Editor030217 neurology & neurosurgerySurgical Neurology International
researchProduct

Letter to the Editor Regarding “Small Aneurysms with Low PHASES Scores Account for a Majority of Subarachnoid Hemorrhage Cases”

2020

medicine.medical_specialtySubarachnoid hemorrhageLetter to the editorbusiness.industryGeneral surgeryIntracranial AneurysmAneurysm RupturedSubarachnoid Hemorrhagemedicine.diseasemedicineHumansSurgeryNeurology (clinical)businessHumanWorld Neurosurgery
researchProduct

Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy

2020

The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, is creating an unprecedented global public health emergency with the continuous growth of infected individuals worldwide. Italy was one of the first European country to face the first wave of infection outside mainland China. The first case of COVID-19 was confirmed in Lombardy on February 20th , 2020, and subsequently, a rapid increase in the number of detected cases was observed, spreading through Italy and the rest of Europe.3 As of April 22nd , confirmed COVID-19 cases in Italy were 183,957.

medicine.medical_specialtyTildrakizumabBiolgical therapy; COVID-19; PsoriasisSettore MED/35PsoriasisChronic Disease; Emergencies; Humans; Italy; Psoriasis; Biological Therapy; COVID-19UstekinumabmedicineAdalimumabHumansPsoriasisbiologicsIntensive care medicineLetter to the Editorpsoriasipsoriasis; biologics; covid-19; pandemicEmergenciePsoriasiRisankizumabbusiness.industrySARS-CoV-2pandemicBiolgical therapyCOVID-19medicine.diseasedermatologyBiological TherapyIxekizumabGuselkumabInfectious Diseasescovid-19ItalyChronic DiseaseSecukinumabEmergenciesbusinessSettore MED/35 - MALATTIE CUTANEE E VENEREEbiologicCOVID-19 psoriasis biological therapiesmedicine.drugHuman
researchProduct